Sanofi (NASDAQ:SNY – Get Free Report) and United-Guardian (NASDAQ:UG – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.
Insider & Institutional Ownership
14.0% of Sanofi shares are owned by institutional investors. Comparatively, 23.2% of United-Guardian shares are owned by institutional investors. 1.0% of Sanofi shares are owned by company insiders. Comparatively, 29.0% of United-Guardian shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility and Risk
Sanofi has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500. Comparatively, United-Guardian has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations and price targets for Sanofi and United-Guardian, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sanofi | 0 | 12 | 8 | 1 | 2.48 |
| United-Guardian | 0 | 1 | 0 | 0 | 2.00 |
Sanofi presently has a consensus price target of $53.00, indicating a potential upside of 8.78%. Given Sanofi’s stronger consensus rating and higher probable upside, equities analysts clearly believe Sanofi is more favorable than United-Guardian.
Dividends
Sanofi pays an annual dividend of $1.76 per share and has a dividend yield of 3.6%. United-Guardian pays an annual dividend of $0.60 per share and has a dividend yield of 7.4%. Sanofi pays out 87.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. United-Guardian pays out 88.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. United-Guardian has increased its dividend for 1 consecutive years. United-Guardian is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Profitability
This table compares Sanofi and United-Guardian’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sanofi | 8.70% | 15.16% | 8.48% |
| United-Guardian | 25.16% | 27.84% | 23.68% |
Valuation & Earnings
This table compares Sanofi and United-Guardian”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sanofi | $50.98 billion | 2.32 | $8.84 billion | $2.02 | 24.12 |
| United-Guardian | $10.55 million | 3.53 | $2.11 million | $0.68 | 11.94 |
Sanofi has higher revenue and earnings than United-Guardian. United-Guardian is trading at a lower price-to-earnings ratio than Sanofi, indicating that it is currently the more affordable of the two stocks.
About Sanofi
Sanofi is a France-based global biopharmaceutical company that researches, develops, manufactures and markets medicines and vaccines. Its work spans areas including immunology, oncology, rare diseases and neurology, as well as preventive vaccines. The company’s portfolio includes Dupixent, an immunology medicine developed with Regeneron, and vaccines for diseases such as influenza and meningitis. Sanofi serves patients and healthcare providers in markets around the world. Sanofi traces its origins to a company established in France in 1973.
About United-Guardian
United-Guardian, Inc. develops and manufactures specialty products for personal care, pharmaceutical, medical and industrial applications. Its offerings include ingredients used in skin-care and cosmetic formulations, as well as medical products. The company’s product lines include Lubrajel®, a range of water-based gel products used in personal-care and medical applications, and Renacidin®, a prescription irrigation solution. United-Guardian sells its products in the United States and internationally.
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
